Differential increases in brain levels of neuropeptide Y and vasoactive intestinal polypeptide after kainic acid-induced seizures in the rat
- 1 January 2004
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 339-339 (1-2) , 173-177
- https://doi.org/10.1007/bf00165140
Abstract
Changes in immunoreactivities of neuropeptide Y (NPY) and vasoactive intestinal polypeptide (VIP) were investigated in the brain of rats after severe kainic acid (KA, 10 mg/kg, i.p.) induced limbic seizures. Decreased levels of both neuropeptides were observed in the frontal cortex, striatum, dorsal hippocampus and amygdala/pyriform cortex subsequently to the period of acute seizures (3 h after injection of the toxin). Then NPY increased consistently in the frontal cortex, hippocampus and amygdala/pyriform cortex. Highest levels (290% of controls) were found in the frontal cortex after two months. Anticonvulsant therapy with phenobarbital (20 mg/kg, i.p., twice daily for three weeks) partially suppressed the rise in NPY levels. Immunoreactivity of VIP increased (to 150%) in the frontal cortex only transiently 3 days after injection of kainic acid. At the subsequently examined time intervals (10–60 days after kainic acid) it declined to control values. Levels decreasing subsequently to acute seizures reflect increased release and degradation of the respective peptide. Increased NPY levels suggest “upregulation” of NPY/ somatostatin/GABA neurons due to the decreased seizure threshold of the animals. The early, reversible rise of VIP in the cortex points to a short-lasting activation of this peptide system contained in local cholinergic neurons. This may be a consequence either of the acute seizures or subsequent neuropathological changes.Keywords
This publication has 20 references indexed in Scilit:
- Limbic seizure and brain damage produced by kainic acid: Mechanisms and relevance to human temporal lobe epilepsyPublished by Elsevier ,2003
- Concomitant increase of somatostatin, neuropeptide y and glutamate decar☐ylase in the frontal cortex of rats with decreased seizure thresholdNeuroscience, 1988
- Long-Term Neuropathological and Neurochemical Effects of Nucleus Basalis Lesions in the RatScience, 1987
- Co-localization of GABA and neuropeptides in neocortical neuronsTrends in Neurosciences, 1986
- Cysteamine suppresses kindled seizures in pentylenetetrazol-kindled ratsEuropean Journal of Pharmacology, 1984
- Changes in immunoreactive somatostatin in brain following lidocaine-induced kindling in ratNeuropharmacology, 1984
- Neuropeptide-containing neurons of the cerebral cortex are also GABAergic.Proceedings of the National Academy of Sciences, 1984
- Two types of cholinergic innervation in cortex, one co-localized with vasoactive intestinal polypeptideNature, 1984
- Profound suppression of kindled seizures by cysteamine: possible role of somatostatin to kindled seizuresBrain Research, 1983
- Changes of immunoreactive somatostatin and β-endorphin content in rat brain after amygdaloid kindlingLife Sciences, 1983